Concepedia

Eric Wadman

EW

13

Publications

427

Citations

12

H-Index

1992

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Janssen (United States)

Bristol-Myers Squibb (Germany)

Eric Wadman is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1992–2017

13

Publications

13

Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.

Carrie Brodmerkel, Eric Wadman, Richard G. Langley et al. · PubMed · 2013 · 69 citations

Discovery of CC Chemokine Receptor-3 (CCR3) Antagonists with Picomolar Potency

George V. De Lucca, Ui Tae Kim, Brian J. Vargo et al. · Journal of Medicinal Chemistry · 2005 · 62 citations · Full text

Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis

Hui-Man Cheng, Yang‐Chang Wu, Qingmin Wang et al. · BMC Complementary and Alternative Medicine · 2017 · 54 citations · Full text

CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure–activity relationships

Dean A. Wacker, Joseph B. Santella, Daniel S. Gardner et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 46 citations · Full text

, , +10

Selective Inhibition of Eosinophil Influx into the Lung by Small Molecule CC Chemokine Receptor 3 Antagonists in Mouse Models of Allergic Inflammation

Anuk Das, Krishna Vaddi, Kimberly A. Solomon et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 40 citations

Rows per page

1–5 of 13